In his personal capacity, Altman has invested in AI, energy, healthcare, finance, technology, cybersecurity, and other ...

Tyler Johnston has been compiling public data about OpenAI's operations for a year, and is now preparing a report to ...

That report, dubbed The OpenAI Files, is out today. It’s a collaboration between the Midas Project and the Tech Oversight ...

The partnership, worth over US$35 million, will further develop MCRI's field-leading research and technology by licensing the blood stem cell discovery IP to Retro Biosciences for the development ...

According to its website, Retro BioScience focuses on “cellular reprogramming” and is less than four years away from developing a clinical proof-of-concept. It vows to extend human life by 10 ...

The final trailer of The Fantastic Four: First Steps sets the stage for an exciting battle between superheroes and a cosmic entity. Scheduled to release on July 25 worldwide, the events shown in the ...

Georgia-raised country performer Willow Avalon talks about vintage dresses, her keys to survival and her album "Southern ...

At 50, Pedro Pascal has made his way to the top of every director’s wish list while also becoming a sex symbol. A funny, sad, ...

Pacific Biosciences (PACB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced new data from the Phase 4 KINECT-PROTM open-label study demonstrating robust and sustained improvements in physical, social and ...

Syndeio Biosciences (derived from Ancient Greek and meaning “to connect”) is a clinical-stage biotechnology company developing therapies to restore and enhance synaptic health in CNS disorders.